When we drew values from cumulative distributions around the median CD4 counts at diagnosis in the different settings in the probabilistic sensitivity analysis, screening of index patients in STD clinics became cost-effective compared with ED diagnosis (an ICER of $44,000 per QALY in Table 6). Here, CD4 is linked to sexually transmitted disease.